Involvement of angiotensin II type 1 receptors in interleukin-1β-induced interleukin-6 production in human gingival fibroblasts

European Journal of Oral Sciences

Volumn 119, Issue 5, 2011, Pages 345-351

  Nakamura, Toshiaki ^a   Hasegawa Nakamura, Kozue ^a   Sakoda, Kenji ^a   Matsuyama, Takashi ^a   Noguchi, Kazuyuki ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Angiotensin type 1 receptor; Gingival fibroblasts; Interleukin 1 ; Interleukin 6; Renin angiotensin system

Indexed keywords

ACE PROTEIN, HUMAN; AGTR1 PROTEIN, HUMAN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN; CATHEPSIN D; CTSD PROTEIN, HUMAN; DIPEPTIDYL CARBOXYPEPTIDASE; IL6 PROTEIN, HUMAN; INTERLEUKIN 1BETA; INTERLEUKIN 6; RENIN; SMALL INTERFERING RNA;

ARTICLE; BIOSYNTHESIS; CELL CULTURE; COMPARATIVE STUDY; DOWN REGULATION; DRUG EFFECT; FIBROBLAST; GENE SILENCING; GENETICS; GINGIVA; GINGIVITIS; HUMAN; METABOLISM; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANGIOTENSINOGEN; CATHEPSIN D; CELLS, CULTURED; DOWN-REGULATION; FIBROBLASTS; GENE SILENCING; GINGIVA; GINGIVITIS; HUMANS; INTERLEUKIN-1BETA; INTERLEUKIN-6; PEPTIDYL-DIPEPTIDASE A; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN; RENIN-ANGIOTENSIN SYSTEM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING;

EID: 80052517544     PISSN: 09098836     EISSN: 16000722     Source Type: Journal    
DOI: 10.1111/j.1600-0722.2011.00850.x     Document Type: Article

References (44)

1. Oparil S, Haber E. The renin-angiotensin system (first of two parts). N Engl J Med 1974; 291: 389-401.
2. Oparil S, Haber E. The renin-angiotensin system (second of two parts). N Engl J Med 1974; 291: 446-457.
3. Paul M, Poyan Mehr A, Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev 2006; 86: 747-803.
4. Goossens GH, Blaak EE, Van Baak MA. Possible involvement of the adipose tissue renin-angiotensin system in the pathophysiology of obesity and obesity-related disorders. Obes Rev 2003; 4: 43-55.
5. Carey RM, Siragy HM. The intrarenal renin-angiotensin system and diabetic nephropathy. Trends Endocrinol Metab 2003; 14: 274-281.
6. Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Suzuki Y, Mezzano S, Plaza JJ, Egido J. Role of the renin-angiotensin system in vascular diseases: expanding the field. Hypertension 2001; 38: 1382-1387.
7. Hunyady L, Catt KJ. Pleiotropic AT1 receptor signaling pathways mediating physiological and pathogenic actions of angiotensin II. Mol Endocrinol 2006; 20: 953-970.
8. Recinos A, 3rd, LeJeune WS, Sun H, Lee CY, Tieu BC, Lu M, Hou T, Boldogh I, Tilton RG, Brasier AR. Angiotensin II induces IL-6 expression and the Jak-STAT3 pathway in aortic adventitia of LDL receptor-deficient mice. Atherosclerosis 2007; 194: 125-133.
9. Yoshida H, Imaizumi T, Tanji K, Sakaki H, Metoki N, Sato Y, Wakabayashi K, Kimura H, Satoh K. Interleukin-1beta enhances the angiotensin-induced expression of plasminogen activator inhibitor-1 through angiotensin receptor upregulation in human astrocytes. Brain Res 2006; 1074: 38-47.
10. Gurantz D, Cowling RT, Varki N, Frikovsky E, Moore CD, Greenberg BH. IL-1beta and TNF-alpha upregulate angiotensin II type 1 (AT1) receptors on cardiac fibroblasts and are associated with increased AT1 density in the post-MI heart. J Mol Cell Cardiol 2005; 38: 505-515.
11. Havemose-Poulsen A, Holmstrup P. Factors affecting IL-1-mediated collagen metabolism by fibroblasts and the pathogenesis of periodontal disease: a review of the literature. Crit Rev Oral Biol Med 1997; 8: 217-236.
12. Kent LW, Rahemtulla F, Michalek SM. Interleukin (IL)-1 and Porphyromonas gingivalis lipopolysaccharide stimulation of IL-6 production by fibroblasts derived from healthy or periodontally diseased human gingival tissue. J Periodontol 1999; 70: 274-282.
13. Santos CF, Akashi AE, Dionisio TJ, Sipert CR, Didier DN, Greene AS, Oliveira SH, Pereira HJ, Becari C, Oliveira EB, Salgado MC. Characterization of a local renin-angiotensin system in rat gingival tissue. J Periodontol 2009; 80: 130-139.
14. Somerman MJ, Archer SY, Imm GR, Foster RA. A comparative study of human periodontal ligament cells and gingival fibroblasts in vitro. J Dent Res 1988; 67: 66-70.
15. Nakamura T, Yamamoto M, Tamura M, Izumi Y. Effects of growth/differentiation factor-5 on human periodontal ligament cells. J Periodontal Res 2003; 38: 597-605.
16. Chertin B, Solari V, Reen DJ, Farkas A, Puri P. Up-regulation of angiotensin-converting enzyme (ACE) gene expression induces tubulointerstitial injury in reflux nephropathy. Pediatr Surg Int 2002; 18: 635-639.
17. Gonda K, Nakaoka T, Yoshimura K, Otawara-Hamamoto Y, Harrii K. Heterotopic ossification of degenerating rat skeletal muscle induced by adenovirus-mediated transfer of bone morphogenetic protein-2 gene. J Bone Miner Res 2000; 15: 1056-1065.
18. Husmann K, Muff R, Bolander ME, Sarkar G, Born W, Fuchs B. Cathepsins and osteosarcoma: expression analysis identifies cathepsin K as an indicator of metastasis. Mol Carcinog 2008; 47: 66-73.
19. Ide N, Hirase T, Nishimoto-Hazuku A, Ikeda Y, Node K. Angiotensin II increases expression of IP-10 and the renin-angiotensin system in endothelial cells. Hypertens Res 2008; 31: 1257-1267.
20. Lin Z, Fitzgerald JB, Xu J, Willers C, Wood D, Grodzinsky AJ, Zheng MH. Gene expression profiles of human chondrocytes during passaged monolayer cultivation. J Orthop Res 2008; 26: 1230-1237.
21. Steckelings UM, Wollschlager T, Peters J, Henz BM, Hermes B, Artuc M. Human skin: source of and target organ for angiotensin II. Exp Dermatol 2004; 13: 148-154.
22. Wandler A, Bruun JM, Nielsen MP, Richelsen B. Ethanol exerts anti-inflammatory effects in human adipose tissue in vitro. Mol Cell Endocrinol 2008; 296: 26-31.
23. Brasier AR, Recinos A, 3rd, Eledrisi MS. Vascular inflammation and the renin-angiotensin system. Arterioscler Thromb Vasc Biol 2002; 22: 1257-1266.
24. Nataraj C, Oliverio MI, Mannon RB, Mannon PJ, Audoly LP, Amuchastegui CS, Ruiz P, Smithies O, Coffman TM. Angiotensin II regulates cellular immune responses through a calcineurin-dependent pathway. J Clin Invest 1999; 104: 1693-1701.
25. Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J. Inflammation and angiotensin II. Int J Biochem Cell Biol 2003; 35: 881-900.
26. Wassmann S, Czech T, Van Eickels M, Fleming I, Bohm M, Nickenig G. Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice. Circulation 2004; 110: 3062-3067.
27. Rasini E, Cosentino M, Marino F, Legnaro M, Ferrari M, Guasti L, Venco A, Lecchini S. Angiotensin II type 1 receptor expression on human leukocyte subsets: a flow cytometric and RT-PCR study. Regul Pept 2006; 134: 69-74.
28. Gross CM, Gerbaulet S, Quensel C, Kramer J, Mittelmeier HO, Luft FC, Dietz R. Angiotensin II type 1 receptor expression in human coronary arteries with variable degrees of atherosclerosis. Basic Res Cardiol 2002; 97: 327-333.
29. Dasu MR, Riosvelasco AC, Jialal I. Candesartan inhibits Toll-like receptor expression and activity both in vitro and in vivo. Atherosclerosis 2009; 202: 76-83.
30. Sano M, Fukuda K, Kodama H, Pan J, Saito M, Matsuzaki J, Takahashi T, Makino S, Kato T, Ogawa S. Interleukin-6 family of cytokines mediate angiotensin II-induced cardiac hypertrophy in rodent cardiomyocytes. J Biol Chem 2000; 275: 29717-29723.
31. Funakoshi Y, Ichiki T, Ito K, Takeshita A. Induction of interleukin-6 expression by angiotensin II in rat vascular smooth muscle cells. Hypertension 1999; 34: 118-125.
32. Kida Y, Kobayashi M, Suzuki T, Takeshita A, Okamatsu Y, Hanazawa S, Yasui T, Hasegawa K. Interleukin-1 stimulates cytokines, prostaglandin E2 and matrix metalloproteinase-1 production via activation of MAPK/AP-1 and NF-kappaB in human gingival fibroblasts. Cytokine 2005; 29: 159-168.
33. Ruiz-Ortega M, Lorenzo O, Suzuki Y, Ruperez M, Egido J. Proinflammatory actions of angiotensins. Curr Opin Nephrol Hypertens 2001; 10: 321-329.
34. Griendling KK, Ushio-Fukai M, Lassegue B, Alexander RW. Angiotensin II signaling in vascular smooth muscle. New concepts. Hypertension 1997; 29: 366-373.
35. Haller H, Lindschau C, Erdmann B, Quass P, Luft FC. Effects of intracellular angiotensin II in vascular smooth muscle cells. Circ Res 1996; 79: 765-772.
36. Morinelli TA, Raymond JR, Baldys A, Yang Q, Lee MH, Luttrell L, Ullian ME. Identification of a putative nuclear localization sequence within ANG II AT(1A) receptor associated with nuclear activation. Am J Physiol Cell Physiol 2007; 292: C1398-1408.
37. Genest J, Cantin M, Garcia R, Thibault G, Gutkowska J, Schiffrin E, Kuchel O, Hamet P. Extrarenal angiotensin-forming enzymes. Clin Exp Hypertens A 1983; 5: 1065-1080.
38. Hoch NE, Guzik TJ, Chen W, Deans T, Maalouf SA, Gratze P, Weyand C, Harrison DG. Regulation of T-cell function by endogenously produced angiotensin II. Am J Physiol Regul Integr Comp Physiol 2009; 296: R208-216.
39. 2+ mobilization by stimulating intracellular AT1 receptors in proximal tubule cells. Am J Physiol Renal Physiol 2006; 290: F1382-1390.
40. Baker KM, Chernin MI, Schreiber T, Sanghi S, Haiderzaidi S, Booz GW, Dostal DE, Kumar R. Evidence of a novel intracrine mechanism in angiotensin II-induced cardiac hypertrophy. Regul Pept 2004; 120: 5-13.
41. Monnouchi S, Maeda H, Fujii S, Tomokiyo A, Kono K, Akamine A. The roles of angiotensin II in stretched periodontal ligament cells. J Dent Res 2011; 90: 181-185.
42. Bakris G. Are there effects of renin-angiotensin system antagonists beyond blood pressure control? Am J Cardiol 2010; 105: 21A-29A.
43. Liu YY, Yao WM, Wu T, Xu BL, Chen F, Cui L. Captopril improves osteopenia in ovariectomized rats and promotes bone formation in osteoblasts. J Bone Miner Metab 2011; 29: 149-158.
44. Gurkan A, Emingil G, Saygan BH, Atilla G, Kose T, Baylas H, Berdeli A. Renin-angiotensin gene polymorphisms in relation to severe chronic periodontitis. J Clin Periodontol 2009; 36: 204-211.